Fig. 2: The clinical potential of MSC-EVs is multifaceted.

They serve as drug carriers, have natural targeting capacity-engineered modifications, and exhibit synergy when combined with biomaterials in bone diseases.

They serve as drug carriers, have natural targeting capacity-engineered modifications, and exhibit synergy when combined with biomaterials in bone diseases.